Report Overview
In the past 2 years, the FDA has approved 3 new drugs for prevention or treatment of hereditary angioedema (HAE) in non-pregnant adolescents and adults: the C1 esterase inhibitor Cinryze for prophylaxis and the C1 esterase inhibitor Berinert and the kallikrein inhibitor ecallantide (Kalbitor) for treatment of acute attacks.
The global Hereditary Angioedema Drug market size was estimated at USD 743 million in 2023 and is projected to reach USD 1343.17 million by 2032, exhibiting a CAGR of 6.80% during the forecast period.
North America Hereditary Angioedema Drug market size was estimated at USD 216.83 million in 2023, at a CAGR of 5.83% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Hereditary Angioedema Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Hereditary Angioedema Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Hereditary Angioedema Drug market in any manner.
Global Hereditary Angioedema Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pharming Group NV
Takeda
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals
Inc.
Ionis Pharmaceuticals
Inc.
Market Segmentation (by Type)
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist
Market Segmentation (by Application)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hereditary Angioedema Drug Market
Overview of the regional outlook of the Hereditary Angioedema Drug Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hereditary Angioedema Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Drug
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Drug Segment by Type
1.2.2 Hereditary Angioedema Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hereditary Angioedema Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Hereditary Angioedema Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hereditary Angioedema Drug Market Competitive Landscape
3.1 Global Hereditary Angioedema Drug Sales by Manufacturers (2019-2025)
3.2 Global Hereditary Angioedema Drug Revenue Market Share by Manufacturers (2019-2025)
3.3 Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Hereditary Angioedema Drug Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Hereditary Angioedema Drug Sales Sites, Area Served, Product Type
3.6 Hereditary Angioedema Drug Market Competitive Situation and Trends
3.6.1 Hereditary Angioedema Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Hereditary Angioedema Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Hereditary Angioedema Drug Industry Chain Analysis
4.1 Hereditary Angioedema Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hereditary Angioedema Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Hereditary Angioedema Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Angioedema Drug Sales Market Share by Type (2019-2025)
6.3 Global Hereditary Angioedema Drug Market Size Market Share by Type (2019-2025)
6.4 Global Hereditary Angioedema Drug Price by Type (2019-2025)
7 Hereditary Angioedema Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Angioedema Drug Market Sales by Application (2019-2025)
7.3 Global Hereditary Angioedema Drug Market Size (M USD) by Application (2019-2025)
7.4 Global Hereditary Angioedema Drug Sales Growth Rate by Application (2019-2025)
8 Hereditary Angioedema Drug Market Consumption by Region
8.1 Global Hereditary Angioedema Drug Sales by Region
8.1.1 Global Hereditary Angioedema Drug Sales by Region
8.1.2 Global Hereditary Angioedema Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Hereditary Angioedema Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Hereditary Angioedema Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Hereditary Angioedema Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Hereditary Angioedema Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Hereditary Angioedema Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Hereditary Angioedema Drug Market Production by Region
9.1 Global Production of Hereditary Angioedema Drug by Region (2019-2025)
9.2 Global Hereditary Angioedema Drug Revenue Market Share by Region (2019-2025)
9.3 Global Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Hereditary Angioedema Drug Production
9.4.1 North America Hereditary Angioedema Drug Production Growth Rate (2019-2025)
9.4.2 North America Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Hereditary Angioedema Drug Production
9.5.1 Europe Hereditary Angioedema Drug Production Growth Rate (2019-2025)
9.5.2 Europe Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Hereditary Angioedema Drug Production (2019-2025)
9.6.1 Japan Hereditary Angioedema Drug Production Growth Rate (2019-2025)
9.6.2 Japan Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Hereditary Angioedema Drug Production (2019-2025)
9.7.1 China Hereditary Angioedema Drug Production Growth Rate (2019-2025)
9.7.2 China Hereditary Angioedema Drug Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Pharming Group NV
10.1.1 Pharming Group NV Hereditary Angioedema Drug Basic Information
10.1.2 Pharming Group NV Hereditary Angioedema Drug Product Overview
10.1.3 Pharming Group NV Hereditary Angioedema Drug Product Market Performance
10.1.4 Pharming Group NV Business Overview
10.1.5 Pharming Group NV Hereditary Angioedema Drug SWOT Analysis
10.1.6 Pharming Group NV Recent Developments
10.2 Takeda
10.2.1 Takeda Hereditary Angioedema Drug Basic Information
10.2.2 Takeda Hereditary Angioedema Drug Product Overview
10.2.3 Takeda Hereditary Angioedema Drug Product Market Performance
10.2.4 Takeda Business Overview
10.2.5 Takeda Hereditary Angioedema Drug SWOT Analysis
10.2.6 Takeda Recent Developments
10.3 CSL Limited
10.3.1 CSL Limited Hereditary Angioedema Drug Basic Information
10.3.2 CSL Limited Hereditary Angioedema Drug Product Overview
10.3.3 CSL Limited Hereditary Angioedema Drug Product Market Performance
10.3.4 CSL Limited Hereditary Angioedema Drug SWOT Analysis
10.3.5 CSL Limited Business Overview
10.3.6 CSL Limited Recent Developments
10.4 IBio Inc.
10.4.1 IBio Inc. Hereditary Angioedema Drug Basic Information
10.4.2 IBio Inc. Hereditary Angioedema Drug Product Overview
10.4.3 IBio Inc. Hereditary Angioedema Drug Product Market Performance
10.4.4 IBio Inc. Business Overview
10.4.5 IBio Inc. Recent Developments
10.5 BioCryst Pharmaceuticals
10.5.1 BioCryst Pharmaceuticals Hereditary Angioedema Drug Basic Information
10.5.2 BioCryst Pharmaceuticals Hereditary Angioedema Drug Product Overview
10.5.3 BioCryst Pharmaceuticals Hereditary Angioedema Drug Product Market Performance
10.5.4 BioCryst Pharmaceuticals Business Overview
10.5.5 BioCryst Pharmaceuticals Recent Developments
10.6 Inc.
10.6.1 Inc. Hereditary Angioedema Drug Basic Information
10.6.2 Inc. Hereditary Angioedema Drug Product Overview
10.6.3 Inc. Hereditary Angioedema Drug Product Market Performance
10.6.4 Inc. Business Overview
10.6.5 Inc. Recent Developments
10.7 Ionis Pharmaceuticals
10.7.1 Ionis Pharmaceuticals Hereditary Angioedema Drug Basic Information
10.7.2 Ionis Pharmaceuticals Hereditary Angioedema Drug Product Overview
10.7.3 Ionis Pharmaceuticals Hereditary Angioedema Drug Product Market Performance
10.7.4 Ionis Pharmaceuticals Business Overview
10.7.5 Ionis Pharmaceuticals Recent Developments
10.8 Inc.
10.8.1 Inc. Hereditary Angioedema Drug Basic Information
10.8.2 Inc. Hereditary Angioedema Drug Product Overview
10.8.3 Inc. Hereditary Angioedema Drug Product Market Performance
10.8.4 Inc. Business Overview
10.8.5 Inc. Recent Developments
11 Hereditary Angioedema Drug Market Forecast by Region
11.1 Global Hereditary Angioedema Drug Market Size Forecast
11.2 Global Hereditary Angioedema Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hereditary Angioedema Drug Market Size Forecast by Country
11.2.3 Asia Pacific Hereditary Angioedema Drug Market Size Forecast by Region
11.2.4 South America Hereditary Angioedema Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Hereditary Angioedema Drug by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Hereditary Angioedema Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Hereditary Angioedema Drug by Type (2025-2032)
12.1.2 Global Hereditary Angioedema Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Hereditary Angioedema Drug by Type (2025-2032)
12.2 Global Hereditary Angioedema Drug Market Forecast by Application (2025-2032)
12.2.1 Global Hereditary Angioedema Drug Sales (K MT) Forecast by Application
12.2.2 Global Hereditary Angioedema Drug Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Hereditary Angioedema Drug Market Size Comparison by Region (M USD)
Table 5. Global Hereditary Angioedema Drug Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Hereditary Angioedema Drug Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Hereditary Angioedema Drug Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Hereditary Angioedema Drug Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Drug as of 2022)
Table 10. Global Market Hereditary Angioedema Drug Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Hereditary Angioedema Drug Sales Sites and Area Served
Table 12. Manufacturers Hereditary Angioedema Drug Product Type
Table 13. Global Hereditary Angioedema Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Hereditary Angioedema Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Angioedema Drug Market Challenges
Table 22. Global Hereditary Angioedema Drug Sales by Type (K MT)
Table 23. Global Hereditary Angioedema Drug Market Size by Type (M USD)
Table 24. Global Hereditary Angioedema Drug Sales (K MT) by Type (2019-2025)
Table 25. Global Hereditary Angioedema Drug Sales Market Share by Type (2019-2025)
Table 26. Global Hereditary Angioedema Drug Market Size (M USD) by Type (2019-2025)
Table 27. Global Hereditary Angioedema Drug Market Size Share by Type (2019-2025)
Table 28. Global Hereditary Angioedema Drug Price (USD/MT) by Type (2019-2025)
Table 29. Global Hereditary Angioedema Drug Sales (K MT) by Application
Table 30. Global Hereditary Angioedema Drug Market Size by Application
Table 31. Global Hereditary Angioedema Drug Sales by Application (2019-2025) & (K MT)
Table 32. Global Hereditary Angioedema Drug Sales Market Share by Application (2019-2025)
Table 33. Global Hereditary Angioedema Drug Sales by Application (2019-2025) & (M USD)
Table 34. Global Hereditary Angioedema Drug Market Share by Application (2019-2025)
Table 35. Global Hereditary Angioedema Drug Sales Growth Rate by Application (2019-2025)
Table 36. Global Hereditary Angioedema Drug Sales by Region (2019-2025) & (K MT)
Table 37. Global Hereditary Angioedema Drug Sales Market Share by Region (2019-2025)
Table 38. North America Hereditary Angioedema Drug Sales by Country (2019-2025) & (K MT)
Table 39. Europe Hereditary Angioedema Drug Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Hereditary Angioedema Drug Sales by Region (2019-2025) & (K MT)
Table 41. South America Hereditary Angioedema Drug Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Hereditary Angioedema Drug Sales by Region (2019-2025) & (K MT)
Table 43. Global Hereditary Angioedema Drug Production (K MT) by Region (2019-2025)
Table 44. Global Hereditary Angioedema Drug Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Hereditary Angioedema Drug Revenue Market Share by Region (2019-2025)
Table 46. Global Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Hereditary Angioedema Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Pharming Group NV Hereditary Angioedema Drug Basic Information
Table 52. Pharming Group NV Hereditary Angioedema Drug Product Overview
Table 53. Pharming Group NV Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Pharming Group NV Business Overview
Table 55. Pharming Group NV Hereditary Angioedema Drug SWOT Analysis
Table 56. Pharming Group NV Recent Developments
Table 57. Takeda Hereditary Angioedema Drug Basic Information
Table 58. Takeda Hereditary Angioedema Drug Product Overview
Table 59. Takeda Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Takeda Business Overview
Table 61. Takeda Hereditary Angioedema Drug SWOT Analysis
Table 62. Takeda Recent Developments
Table 63. CSL Limited Hereditary Angioedema Drug Basic Information
Table 64. CSL Limited Hereditary Angioedema Drug Product Overview
Table 65. CSL Limited Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. CSL Limited Hereditary Angioedema Drug SWOT Analysis
Table 67. CSL Limited Business Overview
Table 68. CSL Limited Recent Developments
Table 69. IBio Inc. Hereditary Angioedema Drug Basic Information
Table 70. IBio Inc. Hereditary Angioedema Drug Product Overview
Table 71. IBio Inc. Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. IBio Inc. Business Overview
Table 73. IBio Inc. Recent Developments
Table 74. BioCryst Pharmaceuticals Hereditary Angioedema Drug Basic Information
Table 75. BioCryst Pharmaceuticals Hereditary Angioedema Drug Product Overview
Table 76. BioCryst Pharmaceuticals Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. BioCryst Pharmaceuticals Business Overview
Table 78. BioCryst Pharmaceuticals Recent Developments
Table 79. Inc. Hereditary Angioedema Drug Basic Information
Table 80. Inc. Hereditary Angioedema Drug Product Overview
Table 81. Inc. Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Inc. Business Overview
Table 83. Inc. Recent Developments
Table 84. Ionis Pharmaceuticals Hereditary Angioedema Drug Basic Information
Table 85. Ionis Pharmaceuticals Hereditary Angioedema Drug Product Overview
Table 86. Ionis Pharmaceuticals Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Ionis Pharmaceuticals Business Overview
Table 88. Ionis Pharmaceuticals Recent Developments
Table 89. Inc. Hereditary Angioedema Drug Basic Information
Table 90. Inc. Hereditary Angioedema Drug Product Overview
Table 91. Inc. Hereditary Angioedema Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Inc. Business Overview
Table 93. Inc. Recent Developments
Table 94. Global Hereditary Angioedema Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 95. Global Hereditary Angioedema Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 96. North America Hereditary Angioedema Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 97. North America Hereditary Angioedema Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 98. Europe Hereditary Angioedema Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 99. Europe Hereditary Angioedema Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 100. Asia Pacific Hereditary Angioedema Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 101. Asia Pacific Hereditary Angioedema Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 102. South America Hereditary Angioedema Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 103. South America Hereditary Angioedema Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 104. Middle East and Africa Hereditary Angioedema Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 105. Middle East and Africa Hereditary Angioedema Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 106. Global Hereditary Angioedema Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 107. Global Hereditary Angioedema Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 108. Global Hereditary Angioedema Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 109. Global Hereditary Angioedema Drug Sales (K MT) Forecast by Application (2025-2032)
Table 110. Global Hereditary Angioedema Drug Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Hereditary Angioedema Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Drug Market Size (M USD), 2019-2032
Figure 5. Global Hereditary Angioedema Drug Market Size (M USD) (2019-2032)
Figure 6. Global Hereditary Angioedema Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Drug Market Size by Country (M USD)
Figure 11. Hereditary Angioedema Drug Sales Share by Manufacturers in 2023
Figure 12. Global Hereditary Angioedema Drug Revenue Share by Manufacturers in 2023
Figure 13. Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Hereditary Angioedema Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Hereditary Angioedema Drug Market Share by Type
Figure 18. Sales Market Share of Hereditary Angioedema Drug by Type (2019-2025)
Figure 19. Sales Market Share of Hereditary Angioedema Drug by Type in 2023
Figure 20. Market Size Share of Hereditary Angioedema Drug by Type (2019-2025)
Figure 21. Market Size Market Share of Hereditary Angioedema Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Hereditary Angioedema Drug Market Share by Application
Figure 24. Global Hereditary Angioedema Drug Sales Market Share by Application (2019-2025)
Figure 25. Global Hereditary Angioedema Drug Sales Market Share by Application in 2023
Figure 26. Global Hereditary Angioedema Drug Market Share by Application (2019-2025)
Figure 27. Global Hereditary Angioedema Drug Market Share by Application in 2023
Figure 28. Global Hereditary Angioedema Drug Sales Growth Rate by Application (2019-2025)
Figure 29. Global Hereditary Angioedema Drug Sales Market Share by Region (2019-2025)
Figure 30. North America Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Hereditary Angioedema Drug Sales Market Share by Country in 2023
Figure 32. U.S. Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Hereditary Angioedema Drug Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Hereditary Angioedema Drug Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Hereditary Angioedema Drug Sales Market Share by Country in 2023
Figure 37. Germany Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Hereditary Angioedema Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Hereditary Angioedema Drug Sales Market Share by Region in 2023
Figure 44. China Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Hereditary Angioedema Drug Sales and Growth Rate (K MT)
Figure 50. South America Hereditary Angioedema Drug Sales Market Share by Country in 2023
Figure 51. Brazil Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Hereditary Angioedema Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Hereditary Angioedema Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Hereditary Angioedema Drug Production Market Share by Region (2019-2025)
Figure 62. North America Hereditary Angioedema Drug Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Hereditary Angioedema Drug Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Hereditary Angioedema Drug Production (K MT) Growth Rate (2019-2025)
Figure 65. China Hereditary Angioedema Drug Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Hereditary Angioedema Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Hereditary Angioedema Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Hereditary Angioedema Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Hereditary Angioedema Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Hereditary Angioedema Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Hereditary Angioedema Drug Market Share Forecast by Application (2025-2032)
